4//SEC Filing
Scoggins Christopher J 4
Accession 0001179110-20-002261
CIK 0000001800other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:10 PM ET
Size
7.2 KB
Accession
0001179110-20-002261
Insider Transaction Report
Form 4
Scoggins Christopher J
Senior Vice President
Transactions
- Award
Option (right to buy)
2020-02-21+68,578→ 68,578 totalExercise: $87.72From: 2021-02-21Exp: 2030-02-20→ Common shares (68,578 underlying) - Award
Common shares without par value
2020-02-21+11,250→ 44,828 total
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,859 on February 21, 2021, 22,859 on February 21, 2022, and 22,860 on February 21, 2023.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001772286
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:10 PM ET
- Size
- 7.2 KB